You are here

TGA Internet site archive

The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.

CMEC Meeting 02, 11 February 1998

Complementary Medicines Evaluation Committee

11 February 1998

Extracted ratified minutes

How to access a pdf document

CMEC Meeting 2 extracted ratified minutes (pdf,25kb)

Public recommendation summary

Item 4.1 Enzyme hydrolysed rice

CMEC agreed:

  • that the following entry be included in Part 5 of Schedule 4 of the TGA Regulations:
    • "Enzyme Hydrolysed Rice (Oryza sativa) [as the appropriate AAN], other than in oral rehydration salts products".

Item 4.2 High amylose maize starch for inclusion in bulk producing fibre

CMEC agreed:

  • that high amylose maize starch is suitable for use in therapeutic goods including in listable goods.

Item 5.1 Zingiber officinale, ginger, Zinax

CMEC agreed:

  • That the sponsor of Zinax be asked to demonstrate the safety of the product in relation to anti coagulant therapy and to suggest the methodology by which they do that by the next meeting.

Request that, unless the Secretariat is notified by a member in writing that this decision record is inaccurate the Secretariat will commence the appropriate action, including communicating the decision to sponsors.

Note: the sponsors of high amylose starch has been given provisional notice of the decision.

Top of page